NPI: 1356496582 · SEATTLE, WA 98124 · General Acute Care Hospital · NPI assigned 01/25/2007
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECREATRY FOR ENROLLMENT) |
| NPI Enumeration Date | 01/25/2007 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 97,840 | $3.13M |
| 2019 | 98,584 | $3.15M |
| 2020 | 78,515 | $2.55M |
| 2021 | 99,715 | $3.18M |
| 2022 | 90,320 | $2.86M |
| 2023 | 80,365 | $2.71M |
| 2024 | 68,711 | $2.47M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 8,784 | 7,873 | $2.44M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,295 | 13,301 | $1.49M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18,060 | 16,797 | $1.35M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 15,170 | 14,209 | $1.21M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 6,116 | 5,971 | $1.04M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 4,833 | 4,696 | $1.00M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,773 | 1,741 | $874K |
| 29581 | 4,644 | 1,943 | $694K | |
| 70450 | Computed tomography, head or brain; without contrast material | 5,460 | 5,166 | $634K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,933 | 1,855 | $490K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,079 | 2,954 | $477K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7,542 | 5,373 | $377K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2,314 | 2,241 | $355K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,237 | 2,154 | $313K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,118 | 4,011 | $304K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,316 | 1,144 | $276K |
| 93017 | 4,073 | 3,936 | $275K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 3,820 | 3,781 | $274K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12,320 | 6,432 | $265K |
| 95811 | 557 | 553 | $241K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,832 | 2,636 | $237K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,799 | 2,692 | $237K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6,823 | 6,381 | $234K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,662 | 2,566 | $230K |
| 76830 | Ultrasound, transvaginal | 2,665 | 2,625 | $225K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 7,974 | 4,314 | $194K |
| 93350 | 945 | 925 | $164K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,839 | 2,609 | $159K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 962 | 932 | $139K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 761 | 750 | $139K |
| 93325 | 1,754 | 1,711 | $138K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1,998 | 1,946 | $131K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,205 | 1,189 | $129K |
| 70496 | 1,762 | 1,694 | $125K | |
| 70498 | 1,530 | 1,476 | $124K | |
| 76801 | 1,844 | 1,766 | $119K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,858 | 2,816 | $117K |
| 93458 | 142 | 138 | $114K | |
| 97597 | 2,274 | 1,312 | $114K | |
| 71046 | Radiologic examination, chest; 2 views | 7,291 | 7,029 | $111K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5,274 | 3,167 | $109K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 5,944 | 3,419 | $105K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1,375 | 1,361 | $99K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,092 | 824 | $96K |
| 76536 | 1,227 | 1,208 | $96K | |
| 95819 | 633 | 616 | $92K | |
| 80053 | Comprehensive metabolic panel | 19,697 | 18,222 | $90K |
| 97162 | 2,172 | 2,116 | $82K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,169 | 1,110 | $81K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 459 | 333 | $73K |
| 72141 | 709 | 690 | $72K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3,739 | 3,556 | $65K |
| 84484 | 16,774 | 11,998 | $61K | |
| 97535 | Self-care/home management training, each 15 minutes | 3,244 | 2,285 | $58K |
| 72110 | 2,309 | 2,277 | $58K | |
| 93970 | 652 | 627 | $53K | |
| 95813 | 120 | 120 | $46K | |
| 77373 | 158 | 39 | $45K | |
| 73562 | 1,573 | 1,517 | $42K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 20,505 | 18,039 | $42K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,085 | 1,041 | $41K |
| 93321 | 543 | 533 | $41K | |
| 72050 | 1,382 | 1,349 | $40K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 442 | 429 | $39K |
| 72156 | 553 | 544 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,497 | 7,345 | $31K |
| G0378 | Hospital observation service, per hour | 3,556 | 1,723 | $28K |
| 83605 | 6,260 | 5,307 | $27K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 522 | 504 | $27K |
| 80047 | 7,131 | 6,691 | $27K | |
| 73030 | 1,701 | 1,598 | $26K | |
| 93880 | 640 | 617 | $26K | |
| J0475 | Injection, baclofen, 10 mg | 136 | 131 | $24K |
| 73630 | 1,569 | 1,488 | $23K | |
| 72100 | 1,620 | 1,572 | $23K | |
| 97161 | 620 | 599 | $22K | |
| 77470 | 37 | 36 | $22K | |
| 73610 | 1,307 | 1,227 | $20K | |
| 73130 | 1,159 | 1,066 | $20K | |
| 83880 | 4,619 | 4,297 | $20K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,930 | 2,073 | $19K |
| 72125 | Computed tomography, cervical spine; without contrast material | 876 | 849 | $19K |
| 84145 | 2,475 | 2,299 | $18K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 27,942 | 25,349 | $16K |
| 71045 | Radiologic examination, chest; single view | 9,556 | 8,838 | $16K |
| 97163 | 450 | 441 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,067 | 3,291 | $15K |
| 71250 | 330 | 323 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,097 | 1,009 | $14K |
| 87040 | 2,288 | 1,251 | $13K | |
| 80076 | 4,243 | 4,057 | $13K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,802 | 10,980 | $13K |
| 73502 | 847 | 823 | $12K | |
| 72082 | 438 | 428 | $11K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 912 | 877 | $10K |
| 73110 | 648 | 598 | $10K | |
| 85379 | 1,799 | 1,741 | $8K | |
| 93978 | 284 | 266 | $8K | |
| 93971 | 81 | 79 | $7K | |
| 72040 | 387 | 374 | $7K | |
| 76377 | 2,948 | 2,829 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 408 | 392 | $6K |
| 62370 | 121 | 117 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 8,324 | 7,343 | $6K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 677 | 600 | $6K |
| 10060 | 26 | 25 | $6K | |
| 75561 | 27 | 26 | $6K | |
| 73564 | 721 | 690 | $5K | |
| 97166 | 195 | 191 | $5K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 36 | 36 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,900 | 1,813 | $5K |
| 84703 | 6,382 | 6,040 | $5K | |
| 77334 | 89 | 52 | $5K | |
| 76770 | 51 | 51 | $4K | |
| 77295 | 15 | 13 | $4K | |
| 97165 | 111 | 103 | $4K | |
| C1769 | Guide wire | 2,181 | 2,066 | $4K |
| 85027 | 4,592 | 4,050 | $4K | |
| 36415 | Collection of venous blood by venipuncture | 6,509 | 4,900 | $4K |
| 77290 | 41 | 37 | $4K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 362 | 346 | $3K |
| 93225 | 132 | 129 | $3K | |
| 85610 | 9,520 | 7,535 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | 2,462 | 2,111 | $3K |
| 82075 | 635 | 582 | $3K | |
| 80305 | 2,278 | 2,163 | $3K | |
| 83690 | 8,855 | 8,312 | $3K | |
| 75574 | 16 | 16 | $3K | |
| 72158 | 24 | 24 | $3K | |
| 72157 | 61 | 61 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 10,894 | 10,349 | $2K |
| 70544 | 29 | 28 | $2K | |
| 82962 | 8,480 | 5,284 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 431 | 413 | $2K |
| 87486 | 423 | 407 | $2K | |
| 87581 | 423 | 407 | $2K | |
| 83735 | 3,258 | 2,799 | $2K | |
| 97116 | 204 | 139 | $2K | |
| 72131 | 36 | 36 | $2K | |
| 90715 | 106 | 104 | $2K | |
| 74174 | 58 | 57 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 856 | 814 | $2K |
| 87081 | 651 | 619 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 66 | 63 | $2K |
| 82553 | 349 | 284 | $2K | |
| 82565 | 3,130 | 2,975 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | 27 | 12 | $2K |
| 85730 | 3,352 | 3,111 | $1K | |
| 93798 | 184 | 52 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 7,297 | 6,560 | $1K |
| 86850 | 1,053 | 991 | $1K | |
| 87631 | 94 | 93 | $1K | |
| 73560 | 39 | 38 | $1K | |
| 82803 | 3,108 | 2,718 | $1K | |
| 96376 | 2,704 | 2,265 | $1K | |
| 76882 | 12 | 12 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,016 | 3,840 | $1K |
| 81003 | 5,767 | 5,514 | $1K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 6,345 | 6,134 | $1K |
| 99152 | 1,471 | 1,406 | $1K | |
| 86900 | 1,741 | 1,214 | $1K | |
| 93312 | 16 | 14 | $1K | |
| 86901 | 1,849 | 1,313 | $1K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,652 | 1,560 | $987.86 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,333 | 3,139 | $941.20 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,232 | 3,812 | $931.92 |
| 77336 | 28 | 24 | $923.86 | |
| 76937 | 12 | 12 | $895.98 | |
| 82728 | 247 | 236 | $865.81 | |
| 99153 | Mod sedat endo service >5yrs | 984 | 933 | $860.88 |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,021 | 2,190 | $808.12 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 898 | 865 | $794.43 |
| 81001 | 5,524 | 5,259 | $792.44 | |
| 87158 | 86 | 72 | $763.32 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,148 | 2,812 | $728.54 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,748 | 1,668 | $669.10 |
| 72070 | 37 | 37 | $642.79 | |
| 94729 | 36 | 36 | $630.14 | |
| 86140 | 1,979 | 1,869 | $589.91 | |
| 77300 | 15 | 13 | $578.80 | |
| 94060 | 12 | 12 | $573.34 | |
| 70486 | 24 | 24 | $569.68 | |
| 77280 | 15 | 13 | $568.33 | |
| 76820 | 13 | 12 | $560.31 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,270 | 1,245 | $475.00 |
| 80061 | Lipid panel | 127 | 119 | $467.74 |
| 97760 | 17 | 14 | $464.92 | |
| 73140 | 27 | 25 | $455.20 | |
| 76813 | 13 | 13 | $452.16 | |
| J1644 | Injection, heparin sodium, per 1000 units | 3,254 | 2,172 | $429.69 |
| J2785 | Injection, regadenoson, 0.1 mg | 1,907 | 1,829 | $396.49 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,694 | 1,563 | $390.51 |
| 84702 | 755 | 731 | $373.61 | |
| 77370 | 15 | 13 | $358.07 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,634 | 878 | $357.98 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,248 | 4,838 | $334.48 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 225 | 220 | $324.64 |
| 73080 | 12 | 12 | $316.58 | |
| 85014 | 555 | 488 | $309.98 | |
| 82550 | 801 | 683 | $308.58 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,091 | 2,636 | $300.31 |
| 83540 | 233 | 223 | $277.34 | |
| J3490 | Unclassified drugs | 715 | 638 | $276.30 |
| C1760 | Closure device, vascular (implantable/insertable) | 60 | 58 | $263.56 |
| J2704 | Injection, propofol, 10 mg | 1,897 | 1,828 | $237.46 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 910 | 843 | $225.88 |
| 93922 | 15 | 15 | $219.18 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,943 | 1,756 | $208.19 |
| 85651 | 1,160 | 1,115 | $207.40 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,177 | 1,963 | $197.73 |
| A9270 | Non-covered item or service | 6,770 | 2,016 | $192.88 |
| 83550 | 154 | 146 | $184.04 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,613 | 2,187 | $176.99 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 422 | 396 | $171.28 |
| 87186 | 449 | 429 | $166.34 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 916 | 876 | $142.57 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 1,409 | 1,381 | $114.86 |
| 73590 | 13 | 12 | $111.93 | |
| 74018 | 26 | 25 | $111.20 | |
| 36000 | 441 | 427 | $92.69 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,896 | 1,747 | $84.64 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,134 | 988 | $82.56 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 579 | 557 | $79.91 |
| 87210 | 155 | 151 | $75.71 | |
| 85347 | 468 | 292 | $75.64 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 668 | 339 | $75.08 |
| 82150 | 947 | 910 | $72.98 | |
| 87070 | 206 | 194 | $69.56 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 153 | 146 | $68.76 |
| 85670 | 96 | 90 | $64.80 | |
| 93925 | 12 | 12 | $50.63 | |
| 87205 | 209 | 195 | $43.36 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,605 | 1,154 | $41.97 |
| 85049 | 60 | 56 | $39.29 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 832 | 712 | $28.03 |
| 85384 | 43 | 41 | $18.87 | |
| 81025 | 508 | 491 | $18.59 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 614 | 575 | $10.02 |
| 87430 | 90 | 88 | $9.50 | |
| J1815 | Injection, insulin, per 5 units | 905 | 479 | $8.72 |
| J1171 | Injection, hydromorphone, 0.1 mg | 43 | 35 | $8.27 |
| 84100 | 79 | 63 | $7.50 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 786 | 642 | $6.90 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 665 | 595 | $6.09 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 29 | 27 | $5.68 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 187 | 172 | $4.36 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 74 | 70 | $4.09 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 99 | 93 | $3.89 |
| 84132 | 15 | 12 | $3.73 | |
| J7050 | Infusion, normal saline solution, 250 cc | 783 | 601 | $2.92 |
| C9113 | Injection, pantoprazole sodium, per vial | 218 | 171 | $0.62 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 395 | 373 | $0.00 |
| 80179 | 72 | 70 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 165 | 156 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 16,934 | 13,053 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 434 | 400 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | 25 | $0.00 |
| G8989 | Self care functional limitation, discharge status, at discharge from therapy or to end reporting | 14 | 14 | $0.00 |
| J2359 | Injection, olanzapine, 0.5 mg | 21 | 14 | $0.00 |
| 93356 | 12 | 12 | $0.00 | |
| 76376 | 14 | 12 | $0.00 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 346 | 330 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 582 | 443 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 118 | 90 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 59 | 58 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 15 | 12 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 14 | 14 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 119 | 109 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 61 | 58 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 114 | 108 | $0.00 |
| 94761 | 143 | 137 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 33 | 30 | $0.00 |